Bibliografía Insuficiencia Mitral

Bibliografía recomendada

 

  1. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, Jneid H, Mack MJ, McLeod CJ, O’Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135:e1159–e1195. DOI: 10.1161/CIR.0000000000000503
    Disponible en: https://www.ahajournals.org/doi/pdf/10.1161/CIR.0000000000000503
     
  2. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm, Ch, Holm, PJ, et.al. Guía ESC/EACTS 2017 sobre el tratamiento de las valvulopatas.  Rev  Esp  Cardiol. 2018; 71(2):110.e1–e47.doi:10.1016/j.recesp.2017.12.014. Disponible aqui
     
  3. Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA Recommendations for noninvasive evaluation of natve valvular regurgitation: a report from the American Society of Echocardiography developed in collabtration with the Society for Cardiovascular Magnetic Resonance.  J Am  Soc Echocardiogr. 2017130(4):303-71. doi: 10.1016/j.echt.2017.01.007. Disponible en: https://asecho.org/wp-content/uploads/2017/04/2017VavularRegurgitationGuideline.pdf
     
  4. Gaasch WH, Meyer TE. Sectndary mitral regurgitattn (part 1): vtlumetric quantficattn and analysis. Heart 20181104(8):634–8. dti:10.1136/heartjnl- 2017-312001. Disponible aquí
     
  5. Gaasch WH, Meyer TE. Secondary mitral regurgitation (part 2): deliberations on mitral surgery and transcatheter repair. Heart. 201810:1-5. doi: 10.1136/heartjnl-2017-312002. Disponible aquí
     
  6. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et.al. Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardíaca aguda y crónica. Rev Esp Cardiol.2016169(12):1167e1-85. http://dx.doi.org/10.1016/j.recesp.2016.10.014. Disponible aquí
     


Bibliografía adicional

 

  • Sala A, Alfieri O. Percutanetus treatment of mitral valve regurgitation: where do we stand?. Int J Cardiol. 2019;288:137-9. DOI:10.1016/j.ijcard.2018.10.004 Disponible aquí
     
  • Deferm S, Bertrand PB, Verbrugge FH, Verhaert D, Rega F, Thomas JD, et.al. Atrial functional mitral regurgitation: JACC review topic of the week. J Am Ctll Cardiol. 2019173(19):2465-76. DOI: 10.1016/j.jacc.2019.02.061. Disponible aquí
     
  • Crestanello JA. Mitral valve surgery for congestive heart failure, Heart Fail Clin. 2018;14(4):585-600. doi: 10.1016/j.hfc.2018.06.006. Disponible aquí
     
  • Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP III, Guyton RA, et.al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:e521–e643.
    Disponible en: https://www.ahajournals.org/doi/pdf/10.1161/CIR.0000000000000031
     

 

suc-beneficios
suc-alianza-ent